SHE/300601 (SHE/300601)

Shenzhen Stock Exchange: SHE/300601 · CNY

CN¥12.5

-0.02 (-0.2%)· Recorded snapshot

Market cap	14B
Revenue (ttm)	2.5B
Net income (ttm)	116.5M
EPS (ttm)	CN¥0.11
Shares out	1.1B
P/E (trailing)	112.4x
P/E (forward)	65.0x
Volume	11,905,487
Beta	0.60

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.5B
Net income (ttm): 116.5M
EPS (ttm): CN¥0.11
P/E (trailing): 112.4x
P/E (forward): 65.0x
Market cap: 14B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E65

P25 n/aP50 n/aP75 n/a

Trailing P/E112.4

P25 n/aP50 n/aP75 n/a

ROE1.2

P25 n/aP50 n/aP75 n/a

ROIC0.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SHE/300601 indicators

Market & fundamental data

Available fields

247

Groups with data

Currency

CNY

Showing 247 of 247 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CNY
Country	China
Country code	CN
Earnings date	2026-10-27
Employees	1,957
Employees change	44
Employees growth	2.3%
Enterprise value	CNY 13.6B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1992
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CNE100002Q33
Last earnings date	2026-10-27
Last refreshed	2026-10-28
Last stock split date	2022-06-02
Last stock split type	Forward
Market cap	CNY 14B
Next earnings date	2026-11-03
Price	CNY 12.53
Price currency	CNY
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	she/300601
Website	https://www.biokangtai.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	110.31x
Average P/E ratio (3Y)	116.24x
Average P/E ratio (5Y)	100.16x
Earnings yield	0.89%
EV/Earnings	116.73x
EV/EBITDA	28.26x
EV/FCF	161.66x
EV/Sales	5.55x
FCF / EV yield	0.62%
FCF yield	0.6%
Forward P/E	65.02x
Graham number	4.66476
Graham upside	-62.77%
Industry forward P/E	18.72x
Industry P/E	33.27x
Lynch fair value	CNY 0.56
Lynch upside	-95.55%
P/B ratio	1.44x
P/E ratio	112.38x
P/FCF ratio	166.33x
P/OCF ratio	26.67x
P/S ratio	5.71x
Price / tangible book value	1.53x
Price/EBITDA ratio	29.07x
Sector forward P/E	20.65x
Sector P/E	37.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	1.24%
EBITDA margin	19.65%
Effective tax rate	7.47%
FCF margin	3.43%
Gross margin	67.24%
Operating margin	1.24%
Pretax margin	4.99%
Profit margin	4.76%
Profit per employee	CNY 59,542
Profitable quarters	7
Profitable years	3
Revenue per employee	CNY 1.3M
ROA	0.13%
ROA (5Y)	2.37%
ROCE	0.25%
ROE	1.17%
ROE (5Y)	5.17%
ROIC	0.31%
ROIC (5Y)	6.07%
Tax / revenue	0.37%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	294.02%
EPS growth (QoQ)	105.08%
EPS growth 10Y	1.39%
EPS growth 3Y	-25.83%
EPS growth 5Y	-37.36%
EPS growth quarters	4
EPS growth years	0
FCF growth	-80.58%
FCF growth (Q)	-58.92%
FCF growth (QoQ)	44.58%
FCF growth 3Y	-11.31%
Gross profit growth	-7.96%
Gross profit growth (Q)	-22.58%
Gross profit growth 3Y	-10.14%
Gross profit growth 5Y	-9.45%
Net income growth (Q)	286.8%
Net income growth (QoQ)	163.77%
Net income growth 3Y	-31.42%
Net income growth 5Y	-38.1%
Net income growth quarters	4
Net income growth years	0
OCF growth	-28.06%
OCF growth (Q)	-20.86%
OCF growth (QoQ)	83.11%
OCF growth 10Y	12.24%
OCF growth 3Y	-16.78%
OCF growth 5Y	-10.05%
Operating income growth (Q)	-40.41%
Operating income growth 3Y	-57.69%
Operating income growth 5Y	-53.32%
Revenue growth	-9.14%
Revenue growth (Q)	-15.42%
Revenue growth (QoQ)	-11.54%
Revenue growth 10Y	18.21%
Revenue growth 3Y	-7.1%
Revenue growth 5Y	-5.3%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CNY -440.7M
Depreciation and amortization	CNY 451.1M
EBIT	CNY 30.3M
EBITDA	CNY 481.4M
EPS	CNY 0.11
FCF per share	CNY 0.08
Financing cash flow	CNY -53.6M
Free cash flow	CNY 84.1M
Gross profit	CNY 1.6B
Income taxes	CNY 9.1M
Investing cash flow	CNY -1.3B
Net borrowing	CNY -3.4M
Net cash flow	CNY -806.9M
Net income	CNY 116.5M
Operating income	CNY 30.3M
Revenue	CNY 2.5B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.06
Book value per share	CNY 8.67
Debt / EBITDA	4.04
Debt / equity	0.2
Debt / FCF	23.1
Interest coverage	0.25
Long-term assets	CNY 7.7B
Long-term liabilities	CNY 2.2B
Net cash (debt)	CNY 414.6M
Net cash / market cap	2.96%
Net debt / EBITDA	-0.86
Net debt / equity	-0.04
Net debt / FCF	-4.93
Piotroski F-Score	6
Property, plant and equipment	CNY 4.6B
Shareholders' equity	CNY 9.7B
Tangible book value	CNY 9.1B
Tangible book value per share	CNY 8.18
Total assets	CNY 13.9B
Total cash	CNY 2.4B
Total debt	CNY 1.9B
Total liabilities	CNY 4.2B
WACC	7.33%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.17
Current assets	CNY 6.2B
Current liabilities	CNY 2B
Current ratio	3.12
Inventory turnover	1.22
Net working capital	CNY 1.9B
Quick ratio	2.52
Working capital	CNY 4.2B
Working capital turnover	0.6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	12.37%
Dividend growth	0%
Dividend growth (3Y)	-29.9%
Dividend growth (5Y)	-19.85%
Dividend growth years	0
Dividend payment date	2026-10-28
Dividend payment years	10
Dividend payout frequency	Annual
Dividend per share	CNY 0.01
Dividend yield	0.04%
Ex-dividend date	2026-10-28
FCF payout ratio	82.3%
Last dividend	CNY 0.03
Payout ratio	64.54%
Shareholder yield	12.41%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CNY 12.88
1D price change	-0.18%
1M price change	-2.72%
1M total return	-2.51%
1W price change	1.21%
1W total return	1.43%
1Y price change	-24.43%
1Y return CAGR	-24.05%
1Y total return	-24.04%
20-day SMA	CNY 12.76
200-day SMA	CNY 13.46
3M price change	3.55%
3M total return	3.78%
3Y price change	-57.06%
3Y return CAGR	-23.97%
3Y total return	-56.06%
50-day SMA	CNY 12.69
50-day SMA vs 200-day SMA	50under200
52-week high	CNY 17.76
52-week high date	2025-11-11
52-week low	CNY 10.70
52-week low date	2026-06-29
5Y price change	-82.43%
5Y return CAGR	-28.77%
5Y total return	-81.66%
6M price change	-10.88%
6M total return	-10.42%
All-time high	CNY 156.06
All-time high date	2020-08-04
All-time low	CNY 1.82
All-time low date	2017-02-07
Average true range (ATR)	CNY 0.49
Average volume	17.2M
Beta (1Y)	0.43
Beta (2Y)	0.5
Beta (5Y)	0.6
Change from 52-week high	-29.45%
Change from 52-week low	17.1%
Change from all-time high	-91.97%
Change from all-time low	589.98%
Change from open	5.29%
Day's gap	-5.18%
Dollar volume	CNY 149.2M
High price	CNY 12.75
Low price	CNY 11.90
Monthly RSI	38.49
Open price	CNY 11.90
Position in 52-week range	74.12%
Previous close	CNY 12.55
Price vs 150-day SMA	-2.69%
Price vs 20-day SMA	-1.83%
Price vs 200-day SMA	-6.87%
Price vs 50-day SMA	-1.25%
Relative volume	0.65
RSI	48.56
Sharpe ratio	-0.57
Sharpe ratio (3Y)	-0.44
Sharpe ratio (5Y)	-0.74
Sortino ratio	-0.75
Sortino ratio (3Y)	-0.57
Sortino ratio (5Y)	-1
Volume	11.9M
Weekly RSI	46.15
YTD price change	-15.17%
YTD total return	-14.73%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	613M
Shares change (QoQ)	28.62%
Shares change (YoY)	-12.37%
Shares held by insiders	45.11%
Shares held by institutions	10.67%
Shares outstanding	1.1B

Deeper analysis on SHE/300601

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SHE/300601 report

Is a complete SHE/300601 research report available?

No complete published report is available for she/300601 (SHE/300601) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SHE/300601 (SHE/300601)

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/300601

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/300601 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SHE/300601

Frequently asked questions